← Back to Search

Behavioral Intervention

Text Messaging Program for HIV Prevention (SHAG Trial)

N/A
Recruiting
Research Sponsored by Center for Innovative Public Health Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Assigned male sex at birth and currently have a cisgender identity
Aged 13-20 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention, 3-months post, 6-months post, 9-months post, 12-month post

Summary

This trial is testing a program called SHAG that uses text messaging to help prevent HIV in young boys and men who are attracted to the same sex. The program will be compared to a control group that

Who is the study for?
This trial is for cisgender sexual minority boys and men aged 13-20 in the U.S. who are interested in participating in an HIV prevention program. The eligibility criteria details are not fully provided, so additional requirements may apply.
What is being tested?
The SHAG program, which uses text messaging to prevent HIV among young guys into guys, is being tested against a control group that receives texts about maintaining a healthy lifestyle.
What are the potential side effects?
Since this trial involves educational text messages rather than medical treatments, there aren't typical side effects like with drugs or surgeries. However, participants might experience increased stress or anxiety related to sexual health discussions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was born male and identify as a man.
Select...
I am between 13 and 20 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention, 3-months post, 6-months post, 9-months post, 12-month post
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention, 3-months post, 6-months post, 9-months post, 12-month post for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
HIV Incidence
Secondary study objectives
Proportion of Participants Testing for an STI
Proportion of Participants having used PrEP/PEP
Self-reported HIV incidence

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SHAG (Sexual Health Advocacy for Guys)Experimental Treatment1 Intervention
Young people assigned to the intervention arm will receive \~9 weeks of daily text messages that talk about healthy sexuality and ways to reduce HIV risk. After a 3 month 'quiet' period, they will receive a week of review messages. Messages are based upon the information-motivation-behavioral model of preventive behavior.
Group II: Attention-matched controlPlacebo Group1 Intervention
Young people assigned to the control arm will receive \~9 weeks of daily text messages that talk about healthy lifestyle, such as self-esteem and physical exercise. After a 3 month 'quiet' period, they will receive a week of review messages.

Find a Location

Who is running the clinical trial?

Center for Innovative Public Health ResearchLead Sponsor
10 Previous Clinical Trials
3,098 Total Patients Enrolled
~3333 spots leftby Jul 2026